Trial Details

UNKNOWN
Basic Information
Clinical ID c1354
Identifier NCT05431283
Trial Title Real-world Effectiveness of Tofacitinib on Ulcerative Colitis Associated Spondyloarthropathy
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis|Spondyloarthropathy
Interventions DRUG: Tofacitinib
Participant Information
Sponsor Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
City Palermo
Country/Region Italy
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2022-04-25
Primary Completion Date 2022-12-31
Completion Date 2023-12-31